SoftMedx Healthcare Resumes Trading After Meeting Stock Exchange Requirements
SoftMedx Healthcare Limited has resumed trading after meeting all Stock Exchange resumption guidance requirements. The company published outstanding financial results with unqualified auditor opinions, ensuring compliance with listing rules. This development enhances its market position and reassures shareholders about its financial health. SoftMedx, part of China Wah Yan Healthcare Group, focuses on distributing medical equipment and products in Hong Kong, generating revenue through sales and supportive services. Current market cap stands at HK$123.9M.
An announcement from China Wah Yan Healthcare ( (HK:0648) ) is now available.
SoftMedx Healthcare Limited has announced the fulfillment of all resumption guidance requirements set by the Stock Exchange, allowing the resumption of trading in its shares. The company has published all outstanding financial results with unqualified opinions from auditors and demonstrated compliance with relevant listing rules. This development marks a significant step in stabilizing its operations and improving its market position, offering reassurance to shareholders and potential investors about its financial health and compliance status.
More about China Wah Yan Healthcare
SoftMedx Healthcare Limited, operating as part of the China Wah Yan Healthcare Group, is primarily engaged in the medical and well-being sector, focusing on the distribution of medical and healthcare equipment and products in Hong Kong. The company generates revenue through the sale of devices and consumable products, as well as providing supportive services. It is an authorized distributor for ten equipment providers from Asia, Europe, and the United States, offering a diverse range of medical devices and consumables.
Current Market Cap: HK$123.9M
For an in-depth examination of 0648 stock, go to TipRanks’ Overview page.
